Skip to main content
Premium Trial:

Request an Annual Quote

Michael Sweeney, Clive Brown

Premium

Michael Sweeney has become a general partner of venture capital firm InterWest Partners of Menlo Park, Calif. In his new position, he will help the company identify investment opportunities in the life sciences. Sweeney joined InterWest in 1998 as an entrepreneur in residence and went on to become a venture partner in 2001. Among a host of other companies, he represents InterWest’s portfolio com-pany Fluidigm.

 

Clive Brown has become head of bioinformatics at Little Chesterfield, UK-based Solexa. Prior to that, he was a bioinformatics consultant for Oxford GlycoSciences, where he was involved with the Protein Atlas of the Human Genome. He also consulted for a number of other biotechnology companies. Before that, Brown held various positions at the Wellcome Trust Center for Human Genetics in Oxford, GlaxoWellcome, and the Sanger Institute.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.